Plexus (PLXS) Financials

$121.92 -0.26 (-0.21%)

As of 04:00 PM Eastern

Annual Income Statements for Plexus

This table shows Plexus' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	94	76	112	13	109	117	141	138	151	147
Consolidated Net Income / (Loss)	94	76	112	13	109	117	139	138	139	112
Net Income / (Loss) Continuing Operations	94	76	112	13	109	117	139	138	139	112
Total Pre-Tax Income	106	87	122	108	126	135	160	158	161	130
Total Operating Income	115	99	130	118	142	153	176	178	196	168
Total Gross Profit	240	227	256	258	292	313	323	347	395	379
Total Revenue	2,654	2,556	2,528	2,874	3,164	3,390	3,369	3,811	4,210	3,961
Operating Revenue	2,654	2,556	2,528	2,874	3,164	3,390	3,369	3,811	4,210	3,961
Total Cost of Revenue	2,415	2,329	2,272	2,616	2,873	3,078	3,046	3,464	3,816	3,582
Operating Cost of Revenue	2,415	2,329	2,272	2,616	2,873	3,078	3,046	3,464	3,816	3,582
Total Operating Expenses	124	128	126	139	150	159	147	169	199	211
Selling, General & Admin Expense	122	121	126	139	148	153	144	167	176	191
Restructuring Charge	1.70	7.03	0.00	0.00	1.68	6.00	3.27	2.02	23	20
Total Other Income / (Expense), net	-9.14	-12	-8.09	-11	-16	-18	-16	-20	-35	-38
Interest Expense	14	15	14	12	13	16	14	16	32	29
Interest & Investment Income	3.50	4.24	5.04	4.70	1.95	1.88	1.37	1.31	3.14	3.86
Other Income / (Expense), net	1.32	-1.65	0.45	-3.14	-5.20	-3.69	-2.98	-5.33	-6.40	-13
Income Tax Expense	12	11	9.76	95	17	18	21	20	22	18
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-	-	-	-	-	-5.32	-	-22	-54
Basic Earnings per Share	$2.81	$2.29	$3.33	$0.40	$3.59	$4.02	$4.86	$4.96	$5.04	$4.08
Weighted Average Basic Shares Outstanding	33.62M	33.37M	33.61M	33.00M	30.27M	29.20M	28.58M	27.86M	27.58M	27.40M
Diluted Earnings per Share	$2.74	$2.24	$3.24	$0.38	$3.50	$3.93	$4.76	$4.86	$4.95	$4.01
Weighted Average Diluted Shares Outstanding	34.38M	34.10M	34.55M	33.92M	31.07M	29.92M	29.17M	28.44M	28.11M	27.91M
Weighted Average Basic & Diluted Shares Outstanding	33.60M	33.40M	33.70M	32.60M	29.18M	29.20M	28.00M	27.63M	27.47M	27.09M

This table shows Plexus' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Income / (Loss) Attributable to Common Shareholders	37	50	42	47	16	46	29	16	18	83	37
Consolidated Net Income / (Loss)	37	50	42	41	16	40	29	16	25	41	37
Net Income / (Loss) Continuing Operations	37	50	42	41	16	40	29	16	25	41	37
Total Pre-Tax Income	43	57	49	48	17	46	35	19	30	45	43
Total Operating Income	50	62	57	57	28	53	45	29	39	54	47
Total Gross Profit	94	107	101	103	94	97	88	88	94	108	101
Total Revenue	981	1,124	1,094	1,071	1,022	1,024	983	967	961	1,051	976
Operating Revenue	981	1,124	1,094	1,071	1,022	1,024	983	967	961	1,051	976
Total Cost of Revenue	888	1,017	993	968	928	927	894	879	866	943	875
Operating Cost of Revenue	888	1,017	993	968	928	927	894	879	866	943	875
Total Operating Expenses	44	45	44	46	65	43	43	59	55	54	54
Selling, General & Admin Expense	44	45	44	46	42	43	43	48	46	54	49
Restructuring Charge	0.00	-	-	0.00	23	-	0.00	11	9.22	-	4.68
Total Other Income / (Expense), net	-6.28	-5.37	-7.90	-9.14	-11	-6.94	-10	-11	-8.94	-8.44	-3.37
Interest Expense	3.92	5.54	6.89	8.29	8.23	8.13	7.62	8.29	7.39	5.58	3.55
Interest & Investment Income	0.32	0.45	0.93	0.76	0.60	0.85	0.81	0.82	1.02	1.22	1.23
Other Income / (Expense), net	-2.68	-0.28	-1.94	-1.61	-3.19	0.35	-3.50	-3.03	-2.57	-4.09	-1.05
Income Tax Expense	5.78	6.49	7.25	6.96	1.58	6.14	5.63	2.73	5.16	4.19	6.23
Basic Earnings per Share	$1.35	$1.81	$1.53	$1.48	$0.57	$1.46	$1.06	$0.59	$0.92	$1.51	$1.38
Weighted Average Basic Shares Outstanding	27.74M	27.86M	27.64M	27.66M	27.56M	27.58M	27.49M	27.54M	27.36M	27.40M	27.09M
Diluted Earnings per Share	$1.33	$1.76	$1.49	$1.45	$0.56	$1.45	$1.04	$0.58	$0.91	$1.48	$1.34
Weighted Average Diluted Shares Outstanding	28.18M	28.44M	28.31M	28.18M	27.99M	28.11M	28.01M	27.93M	27.77M	27.91M	27.76M
Weighted Average Basic & Diluted Shares Outstanding	27.71M	27.63M	27.70M	27.65M	-	27.47M	27.61M	27.39M	27.23M	27.09M	27.04M

This table details how cash moves in and out of Plexus' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	16	80	135	-273	-71	162	-117	4.96	-19	91
Net Cash From Operating Activities	77	128	172	67	115	210	143	-26	166	437
Net Cash From Continuing Operating Activities	77	128	172	67	115	210	143	-26	166	437
Net Income / (Loss) Continuing Operations	94	76	112	13	109	117	139	138	139	112
Consolidated Net Income / (Loss)	94	76	112	13	109	117	139	138	139	112
Depreciation Expense	48	47	45	48	52	57	61	63	70	78
Non-Cash Adjustments To Reconcile Net Income	13	21	18	1.07	57	8.61	113	481	-4.22	51
Changes in Operating Assets and Liabilities, net	-80	-17	-3.22	4.42	-102	28	-170	-708	-39	196
Net Cash From Investing Activities	-35	-27	-38	-75	-89	-50	-57	-102	-93	-95
Net Cash From Continuing Investing Activities	-35	-27	-38	-75	-89	-50	-57	-102	-93	-95
Purchase of Property, Plant & Equipment	-35	-31	-39	-63	-91	-50	-57	-102	-104	-95
Other Investing Activities, net	-	-	0.00	0.00	1.24	0.24	0.13	0.05	11	0.24
Net Cash From Financing Activities	-26	-21	1.31	-265	-97	-1.46	-204	139	-93	-256
Net Cash From Continuing Financing Activities	-26	-21	1.31	-265	-97	-1.46	-204	139	-93	-256
Repayment of Debt	-488	-630	-303	-971	-994	-639	-466	-558	-788	-739
Repurchase of Common Equity	-30	-30	-34	-137	-182	-41	-108	-50	-41	-56
Issuance of Debt	483	625	331	834	1,085	679	377	758	749	551
Other Financing Activities, net	8.61	14	7.25	8.22	-5.42	-0.11	-6.11	-11	-12	-11
Other Net Changes in Cash	-	-	-	-	-	-	-	-	-	4.84
Cash Interest Paid	13	15	14	12	16	15	14	15	33	30
Cash Income Taxes Paid	11	11	10	19	26	31	40	17	44	46

This table details how cash moves in and out of Plexus' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Net Change in Cash & Equivalents	-31	-2.36	-28	22	-	3.10	-24	33	4.80	78	-30
Net Cash From Operating Activities	-21	-0.39	-49	106	-	90	-3.03	88	132	220	54
Net Cash From Continuing Operating Activities	-21	-0.39	-49	106	-	90	-3.03	88	132	220	54
Net Income / (Loss) Continuing Operations	37	50	42	41	-	40	29	16	25	41	37
Consolidated Net Income / (Loss)	37	50	42	41	-	40	29	16	25	41	37
Depreciation Expense	16	16	16	17	-	18	19	19	20	20	19
Non-Cash Adjustments To Reconcile Net Income	24	283	1.40	-6.54	-	-41	-36	8.35	14	24	-82
Changes in Operating Assets and Liabilities, net	-99	-350	-109	54	-	72	-15	44	73	136	79
Net Cash From Investing Activities	-21	-16	-22	-26	-	-16	-29	-23	-18	-26	-26
Net Cash From Continuing Investing Activities	-21	-16	-22	-26	-	-16	-29	-23	-18	-26	-26
Purchase of Property, Plant & Equipment	-21	-17	-23	-26	-	-24	-29	-23	-17	-26	-27
Other Investing Activities, net	-0.03	0.16	1.50	0.37	-	8.66	0.07	0.27	-0.21	0.11	0.05
Net Cash From Financing Activities	14	17	39	-58	-	-70	5.76	-31	-109	-121	-53
Net Cash From Continuing Financing Activities	14	17	39	-58	-	-70	5.76	-31	-109	-121	-53
Repayment of Debt	-121	-214	-142	-194	-	-242	-124	-202	-213	-200	-76
Repurchase of Common Equity	-12	-3.48	-11	-12	-	-3.52	0.00	-18	-19	-20	-13
Issuance of Debt	147	234	197	157	-	176	133	196	123	99	40
Other Financing Activities, net	-0.05	0.15	-4.09	-8.19	-	-0.17	-2.91	-7.91	-0.01	-0.12	-3.07
Effect of Exchange Rate Changes	-3.32	-2.69	3.38	0.40	-	-0.83	1.62	-1.13	-0.57	-	-4.01

This table presents Plexus' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,692	1,766	1,976	1,933	2,001	2,290	2,462	3,393	3,321	3,154
Total Current Assets	1,334	1,433	1,617	1,517	1,538	1,779	1,931	2,816	2,672	2,477
Cash & Equivalents	357	433	569	297	224	386	270	275	256	345
Restricted Cash	-	0.00	0.39	0.42	2.49	2.09	0.34	0.67	0.42	2.35
Accounts Receivable	385	417	366	395	488	482	520	738	662	622
Inventories, net	569	564	655	794	701	763	972	1,603	1,562	1,311
Prepaid Expenses	23	19	28	30	32	32	53	62	50	75
Other Current Assets	-	-	-	0.00	91	114	115	139	142	121
Plant, Property, & Equipment, net	317	291	315	341	384	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	40	41	44	74	78	511	531	577	649	677
Noncurrent Deferred & Refundable Income Taxes	4.66	4.83	5.29	11	14	21	27	39	63	74
Other Noncurrent Operating Assets	36	36	39	63	65	489	504	538	586	603
Total Liabilities & Shareholders' Equity	1,692	1,766	1,976	1,933	2,001	2,290	2,462	3,393	3,321	3,154
Total Liabilities	849	849	950	1,011	1,135	1,312	1,434	2,297	2,107	1,829
Total Current Liabilities	579	650	908	738	866	1,004	1,129	2,006	1,813	1,643
Short-Term Debt	3.51	79	287	5.53	101	147	66	274	240	157
Accounts Payable	401	397	414	506	445	516	635	806	647	606
Accrued Expenses	-	48	49	68	106	103	147	58	71	76
Current Employee Benefit Liabilities	49	42	49	67	74	77	75	89	94	94
Other Current Liabilities	44	-	-	-	-	-	-	779	760	709
Total Noncurrent Liabilities	270	199	43	274	270	309	305	291	294	186
Long-Term Debt	258	184	26	183	-	-	187	188	191	90
Noncurrent Deferred Revenue	-	-	0.00	56	60	54	48	42	31	17
Noncurrent Deferred & Payable Income Tax Liabilities	-	-	0.00	14	5.31	6.43	5.68	6.33	4.35	8.23
Other Noncurrent Operating Liabilities	12	15	16	20	18	61	64	55	68	70
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	842	917	1,026	921	866	977	1,028	1,096	1,214	1,325
Total Preferred & Common Equity	842	917	1,026	921	866	977	1,028	1,096	1,214	1,325
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	842	917	1,026	921	866	977	1,028	1,096	1,214	1,325
Common Stock	498	531	556	582	598	622	640	653	662	681
Retained Earnings	861	937	1,049	1,062	1,179	1,295	1,434	1,572	1,711	1,823
Treasury Stock	-510	-	-	-	-	-	-1,043	-1,093	-1,134	-1,190
Accumulated Other Comprehensive Income / (Loss)	-6.47	-12	-4.98	-12	-18	-5.06	-2.98	-36	-24	11

This table presents Plexus' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025
Total Assets	3,204	3,395	3,382	3,419	3,305	3,277	3,171	3,071
Total Current Assets	2,654	2,814	2,780	2,799	2,650	2,631	2,541	2,387
Cash & Equivalents	277	248	270	253	232	265	270	317
Restricted Cash	1.22	0.03	0.70	0.59	0.43	0.04	0.02	0.69
Accounts Receivable	614	734	661	707	656	646	644	597
Inventories, net	1,561	1,645	1,650	1,642	1,575	1,519	1,434	1,290
Prepaid Expenses	74	68	66	64	55	71	77	54
Other Current Assets	128	119	133	133	132	131	116	128
Plant, Property, & Equipment, net	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Noncurrent Assets	550	581	602	620	654	646	630	684
Noncurrent Deferred & Refundable Income Taxes	27	39	39	40	63	63	55	74
Other Noncurrent Operating Assets	523	542	562	579	592	583	575	610
Total Liabilities & Shareholders' Equity	3,204	3,395	3,382	3,419	3,305	3,277	3,171	3,071
Total Liabilities	2,146	2,245	2,200	2,235	2,038	2,017	1,905	1,752
Total Current Liabilities	1,861	1,954	1,918	1,941	1,744	1,737	1,725	1,565
Short-Term Debt	250	329	294	305	251	246	258	122
Accounts Payable	853	754	729	697	647	627	593	666
Accrued Expenses	298	296	286	277	61	74	63	74
Current Deferred Revenue	-	-	-	-	-	716	-	625
Current Employee Benefit Liabilities	68	64	77	80	75	73	75	78
Total Noncurrent Liabilities	286	291	282	294	294	280	180	187
Long-Term Debt	185	187	189	187	192	-	91	89
Noncurrent Deferred Revenue	42	42	31	31	31	17	17	17
Noncurrent Deferred & Payable Income Tax Liabilities	6.29	5.62	4.90	4.44	4.41	4.43	4.29	7.23
Other Noncurrent Operating Liabilities	52	56	57	70	66	66	68	74
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,058	1,150	1,182	1,184	1,267	1,260	1,266	1,319
Total Preferred & Common Equity	1,058	1,150	1,182	1,184	1,267	1,260	1,266	1,319
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,058	1,150	1,182	1,184	1,267	1,260	1,266	1,319
Common Stock	648	655	652	656	664	664	671	685
Retained Earnings	1,522	1,614	1,655	1,671	1,741	1,757	1,782	1,860
Accumulated Other Comprehensive Income / (Loss)	-21	-14	-7.74	-12	-3.44	-8.70	-16	-24
Other Equity Adjustments	-1,090	-	-	-1,131	-	-	-	-1,203

This table displays calculated financial ratios and metrics derived from Plexus' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	11.61%	-3.70%	-1.09%	13.66%	10.12%	7.14%	-0.64%	13.14%	10.47%	-5.93%
EBITDA Growth	9.65%	-12.23%	21.00%	-6.97%	15.68%	9.15%	13.54%	0.53%	10.03%	-10.33%
EBIT Growth	13.71%	-16.25%	33.31%	-11.67%	18.86%	9.37%	15.77%	-0.25%	9.58%	-18.41%
NOPAT Growth	8.96%	-15.11%	37.42%	-88.01%	754.65%	8.63%	14.70%	1.94%	8.71%	-14.41%
Net Income Growth	8.16%	-18.98%	46.63%	-88.36%	732.94%	8.16%	18.24%	-0.48%	0.62%	-19.61%
EPS Growth	8.73%	-18.25%	44.64%	-88.27%	821.05%	12.29%	21.12%	2.10%	1.85%	-18.99%
Operating Cash Flow Growth	-13.41%	66.82%	34.44%	-61.08%	72.52%	82.45%	-32.23%	-118.40%	731.94%	163.24%
Free Cash Flow Firm Growth	376.38%	55.22%	9.66%	-129.10%	126.02%	1,770.10%	-51.49%	-274.84%	154.09%	395.15%
Invested Capital Growth	6.56%	-0.08%	3.14%	5.49%	14.19%	-0.31%	9.38%	26.80%	8.33%	-11.82%
Revenue Q/Q Growth	0.09%	-0.61%	0.67%	3.66%	1.25%	3.13%	-2.04%	0.00%	0.00%	0.68%
EBITDA Q/Q Growth	-1.45%	-3.63%	5.23%	2.14%	0.97%	7.13%	-2.60%	279.48%	0.00%	-1.15%
EBIT Q/Q Growth	-1.85%	-4.77%	7.26%	2.16%	0.69%	9.25%	-3.89%	0.00%	0.00%	-2.47%
NOPAT Q/Q Growth	-3.17%	-5.24%	10.18%	142.19%	-24.07%	0.25%	-3.82%	0.00%	0.00%	1.95%
Net Income Q/Q Growth	-2.67%	-5.88%	9.71%	142.49%	-24.85%	0.75%	-3.05%	0.00%	0.00%	0.87%
EPS Q/Q Growth	-2.84%	-5.49%	9.46%	140.43%	-21.35%	1.55%	-2.26%	0.00%	0.00%	0.75%
Operating Cash Flow Q/Q Growth	-11.30%	-11.05%	35.17%	-26.79%	255.94%	4.77%	-42.82%	-77.50%	0.00%	42.55%
Free Cash Flow Firm Q/Q Growth	-4.61%	-21.31%	41.40%	-511.61%	108.53%	0.81%	-62.81%	54.59%	130.00%	40.59%
Invested Capital Q/Q Growth	0.43%	3.05%	0.66%	10.43%	-5.57%	-5.65%	5.20%	5.51%	-2.41%	-8.97%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.03%	8.90%	10.12%	8.96%	9.22%	9.22%	9.60%	9.11%	9.37%	9.56%
EBITDA Margin	6.23%	5.68%	6.95%	5.69%	5.97%	6.09%	6.96%	6.18%	6.16%	5.87%
Operating Margin	4.35%	3.89%	5.14%	4.12%	4.49%	4.52%	5.23%	4.68%	4.65%	4.23%
EBIT Margin	4.40%	3.83%	5.16%	4.01%	4.32%	4.41%	5.14%	4.54%	4.50%	3.90%
Profit (Net Income) Margin	3.55%	2.99%	4.43%	0.45%	3.43%	3.47%	4.12%	3.63%	3.30%	2.82%
Tax Burden Percent	88.75%	87.45%	91.99%	12.12%	86.23%	86.77%	86.60%	87.33%	86.39%	86.32%
Interest Burden Percent	91.04%	89.37%	93.45%	93.46%	92.03%	90.46%	92.57%	91.58%	85.00%	83.81%
Effective Tax Rate	11.25%	12.55%	8.01%	87.88%	13.77%	13.23%	13.40%	12.67%	13.61%	13.68%
Return on Invested Capital (ROIC)	14.15%	11.65%	15.76%	1.81%	14.09%	14.37%	15.77%	13.57%	12.67%	11.08%
ROIC Less NNEP Spread (ROIC-NNEP)	23.40%	19.57%	19.25%	2.52%	72.74%	-346.82%	54.86%	-6.96%	-4.01%	-77.73%
Return on Net Nonoperating Assets (RNNOA)	-2.53%	-2.96%	-4.23%	-0.47%	-1.93%	-1.63%	-1.92%	-0.55%	-0.63%	-2.27%
Return on Equity (ROE)	11.62%	8.69%	11.54%	1.34%	12.16%	12.75%	13.85%	13.02%	12.04%	8.81%
Cash Return on Invested Capital (CROIC)	7.79%	11.73%	12.67%	-3.53%	0.84%	14.69%	6.82%	-10.06%	4.67%	23.64%
Operating Return on Assets (OROA)	7.07%	5.66%	6.97%	5.89%	6.96%	6.98%	7.29%	5.90%	5.64%	4.77%
Return on Assets (ROA)	5.72%	4.42%	5.99%	0.67%	5.52%	5.48%	5.85%	4.72%	4.14%	3.45%
Return on Common Equity (ROCE)	11.62%	8.69%	11.54%	1.34%	12.16%	12.75%	13.85%	13.02%	12.04%	8.81%
Return on Equity Simple (ROE_SIMPLE)	11.20%	8.34%	10.92%	1.42%	12.55%	12.02%	13.51%	12.62%	11.45%	8.44%
Net Operating Profit after Tax (NOPAT)	102	87	119	14	122	133	153	156	169	145
NOPAT Margin	3.86%	3.40%	4.73%	0.50%	3.87%	3.93%	4.53%	4.08%	4.02%	3.66%
Net Nonoperating Expense Percent (NNEP)	-9.25%	-7.93%	-3.49%	-0.71%	-58.65%	361.19%	-39.09%	20.53%	16.67%	88.81%
Cost of Revenue to Revenue	90.98%	91.10%	89.88%	91.04%	90.78%	90.78%	90.40%	90.89%	90.63%	90.44%
SG&A Expenses to Revenue	4.61%	4.73%	4.98%	4.85%	4.68%	4.52%	4.27%	4.38%	4.17%	4.81%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	4.68%	5.00%	4.98%	4.85%	4.73%	4.70%	4.36%	4.44%	4.72%	5.32%
Earnings before Interest and Taxes (EBIT)	117	98	130	115	137	150	173	173	189	155
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	165	145	176	163	189	206	234	236	259	232
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	1.55	1.74	1.89	2.15	2.25	2.17	2.58	2.27	2.15	2.87
Price to Tangible Book Value (P/TBV)	1.55	1.74	1.89	2.15	2.25	2.17	2.58	2.27	2.15	2.87
Price to Revenue (P/Rev)	0.49	0.62	0.77	0.69	0.61	0.63	0.79	0.65	0.62	0.96
Price to Earnings (P/E)	13.85	20.87	17.29	152.19	17.90	18.07	18.84	18.01	17.34	25.95
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	7.22%	4.79%	5.78%	0.66%	5.59%	5.53%	5.31%	5.55%	5.77%	3.85%
Enterprise Value to Invested Capital (EV/IC)	1.62	1.91	2.18	2.31	2.16	2.24	2.61	2.09	2.01	3.03
Enterprise Value to Revenue (EV/Rev)	0.46	0.56	0.67	0.65	0.63	0.61	0.78	0.70	0.66	0.94
Enterprise Value to EBITDA (EV/EBITDA)	7.32	9.81	9.57	11.48	10.61	10.03	11.26	11.36	10.76	15.95
Enterprise Value to EBIT (EV/EBIT)	10.37	14.57	12.90	16.29	14.66	13.83	15.23	15.48	14.72	23.99
Enterprise Value to NOPAT (EV/NOPAT)	11.82	16.38	14.07	130.85	16.37	15.55	17.29	17.20	16.48	25.61
Enterprise Value to Operating Cash Flow (EV/OCF)	15.82	11.15	9.79	28.06	17.40	9.84	18.51	0.00	16.82	8.49
Enterprise Value to Free Cash Flow (EV/FCFF)	21.46	16.26	17.51	0.00	275.83	15.22	40.01	0.00	44.70	12.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.31	0.29	0.31	0.20	0.33	0.34	0.25	0.42	0.36	0.19
Long-Term Debt to Equity	0.31	0.20	0.03	0.20	0.22	0.19	0.18	0.17	0.16	0.07
Financial Leverage	-0.11	-0.15	-0.22	-0.19	-0.03	0.00	-0.04	0.08	0.16	0.03
Leverage Ratio	2.03	1.97	1.93	2.01	2.20	2.33	2.37	2.76	2.91	2.55
Compound Leverage Factor	1.85	1.76	1.80	1.88	2.03	2.11	2.19	2.52	2.47	2.14
Debt to Total Capital	23.71%	22.26%	23.38%	17.00%	24.96%	25.51%	19.77%	29.65%	26.20%	15.73%
Short-Term Debt to Total Capital	0.32%	6.66%	21.43%	0.50%	8.73%	11.19%	5.17%	17.59%	14.60%	10.01%
Long-Term Debt to Total Capital	23.39%	15.60%	1.95%	16.50%	16.23%	14.32%	14.59%	12.06%	11.60%	5.72%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	76.29%	77.74%	76.62%	83.00%	75.04%	74.49%	80.23%	70.35%	73.80%	84.27%
Debt to EBITDA	1.58	1.81	1.78	1.15	1.52	1.62	1.08	1.96	1.66	1.06
Net Debt to EBITDA	-0.58	-1.17	-1.46	-0.67	0.33	-0.26	-0.07	0.79	0.67	-0.43
Long-Term Debt to EBITDA	1.56	1.27	0.15	1.12	0.99	0.91	0.80	0.80	0.74	0.39
Debt to NOPAT	2.56	3.02	2.62	13.16	2.35	2.52	1.66	2.97	2.55	1.71
Net Debt to NOPAT	-0.93	-1.96	-2.14	-7.61	0.50	-0.40	-0.11	1.20	1.03	-0.69
Long-Term Debt to NOPAT	2.52	2.12	0.22	12.77	1.53	1.41	1.23	1.21	1.13	0.62
Altman Z-Score	3.97	4.03	3.89	4.11	4.06	3.87	3.92	2.88	3.23	3.79
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.30	2.20	1.78	2.06	1.78	1.77	1.71	1.40	1.47	1.51
Quick Ratio	1.28	1.31	1.03	0.94	0.82	0.86	0.70	0.50	0.51	0.59
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	56	88	96	-28	7.27	136	66	-115	62	309
Operating Cash Flow to CapEx	220.87%	481.74%	453.91%	107.37%	127.26%	420.00%	249.70%	-25.82%	159.37%	458.60%
Free Cash Flow to Firm to Interest Expense	4.04	5.99	7.07	-2.29	0.57	8.41	4.63	-7.27	1.98	10.70
Operating Cash Flow to Interest Expense	5.48	8.73	12.65	5.47	8.97	13.02	10.00	-1.65	5.26	15.12
Operating Cash Flow Less CapEx to Interest Expense	3.00	6.92	9.86	0.38	1.92	9.92	6.00	-8.06	1.96	11.82
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	1.61	1.48	1.35	1.47	1.61	1.58	1.42	1.30	1.25	1.22
Accounts Receivable Turnover	7.49	6.38	6.46	7.56	7.17	6.99	6.73	6.06	6.02	6.17
Inventory Turnover	4.41	4.11	3.73	3.61	3.84	4.20	3.51	2.69	2.41	2.49
Fixed Asset Turnover	8.14	8.40	8.34	8.76	8.72	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	6.06	5.84	5.60	5.68	6.04	6.40	5.29	4.81	5.26	5.72
Days Sales Outstanding (DSO)	48.73	57.23	56.48	48.29	50.93	52.23	54.27	60.21	60.65	59.16
Days Inventory Outstanding (DIO)	82.78	88.83	97.89	101.09	95.00	86.84	104.01	135.66	151.37	146.39
Days Payable Outstanding (DPO)	60.24	62.53	65.15	64.21	60.44	57.00	68.99	75.89	69.46	63.83
Cash Conversion Cycle (CCC)	71.27	83.53	89.22	85.17	85.49	82.07	89.29	119.98	142.56	141.71
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	747	746	770	812	927	924	1,011	1,282	1,389	1,225
Invested Capital Turnover	3.67	3.42	3.33	3.63	3.64	3.66	3.48	3.32	3.15	3.03
Increase / (Decrease) in Invested Capital	46	-0.63	23	42	115	-2.91	87	271	107	-164
Enterprise Value (EV)	1,211	1,425	1,682	1,876	2,006	2,069	2,639	2,676	2,788	3,708
Market Capitalization	1,306	1,595	1,938	1,985	1,944	2,123	2,657	2,490	2,614	3,808
Book Value per Share	$25.04	$27.42	$30.53	$28.58	$29.56	$33.42	$36.40	$39.54	$44.19	$48.66
Tangible Book Value per Share	$25.04	$27.42	$30.53	$28.58	$29.56	$33.42	$36.40	$39.54	$44.19	$48.66
Total Capital	1,104	1,179	1,339	1,110	1,154	1,312	1,282	1,557	1,645	1,572
Total Debt	262	263	313	189	288	335	253	462	431	247
Total Long-Term Debt	258	184	26	183	187	188	187	188	191	90
Net Debt	-95	-170	-256	-109	62	-53	-17	186	174	-100
Capital Expenditures (CapEx)	35	27	38	62	91	50	57	102	104	95
Debt-free, Cash-free Net Working Capital (DFCFNWC)	401	428	428	487	547	535	598	808	843	644
Debt-free Net Working Capital (DFNWC)	758	861	997	785	773	922	868	1,084	1,100	991
Net Working Capital (NWC)	755	783	710	779	673	776	802	810	860	834
Net Nonoperating Expense (NNE)	8.11	11	7.44	1.29	14	16	14	17	30	33
Net Nonoperating Obligations (NNO)	-95	-170	-256	-109	62	-53	-17	186	174	-100
Total Depreciation and Amortization (D&A)	49	47	45	48	52	57	61	63	70	78
Debt-free, Cash-free Net Working Capital to Revenue	15.11%	16.76%	16.91%	16.96%	17.29%	15.77%	17.75%	21.21%	20.02%	16.25%
Debt-free Net Working Capital to Revenue	28.57%	33.70%	39.43%	27.32%	24.44%	27.21%	25.78%	28.44%	26.12%	25.02%
Net Working Capital to Revenue	28.43%	30.63%	28.08%	27.13%	21.26%	22.88%	23.81%	21.25%	20.42%	21.05%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.81	$2.29	$3.33	$0.40	$3.59	$4.02	$4.86	$4.96	$5.04	$4.08
Adjusted Weighted Average Basic Shares Outstanding	33.62M	33.37M	33.61M	33.00M	30.27M	29.20M	28.58M	27.86M	27.58M	27.40M
Adjusted Diluted Earnings per Share	$2.74	$2.24	$3.24	$0.38	$3.50	$3.93	$4.76	$4.86	$4.95	$4.01
Adjusted Weighted Average Diluted Shares Outstanding	34.38M	34.10M	34.55M	33.92M	31.07M	29.92M	29.17M	28.44M	28.11M	27.91M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	33.42M	33.51M	33.59M	31.47M	29.18M	28.82M	28.00M	27.63M	27.47M	27.09M
Normalized Net Operating Profit after Tax (NOPAT)	104	93	119	83	124	138	155	157	189	162
Normalized NOPAT Margin	3.92%	3.64%	4.73%	2.88%	3.92%	4.08%	4.62%	4.13%	4.49%	4.10%
Pre Tax Income Margin	4.00%	3.42%	4.82%	3.74%	3.98%	3.99%	4.76%	4.15%	3.82%	3.27%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	8.36	6.68	9.60	9.42	10.65	9.26	12.16	10.90	6.01	5.35
NOPAT to Interest Expense	7.34	5.94	8.80	1.17	9.53	8.23	10.71	9.81	5.36	5.01
EBIT Less CapEx to Interest Expense	5.88	4.87	6.81	4.33	3.60	6.16	8.15	4.49	2.71	2.06
NOPAT Less CapEx to Interest Expense	4.85	4.13	6.01	-3.92	2.48	5.13	6.70	3.40	2.06	1.72
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	31.80%	39.25%	30.46%	1,050.87%	167.66%	35.23%	78.07%	36.45%	29.44%	49.80%

This table displays calculated financial ratios and metrics derived from Plexus' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024	Q1 2025
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	20.50%	33.28%	33.82%	20.49%	0.00%	-8.89%	-10.18%	-9.71%	-5.96%	2.60%	-0.66%
EBITDA Growth	23.34%	35.40%	59.17%	45.42%	-60.17%	-7.46%	-15.19%	-36.78%	125.56%	-3.75%	7.28%
EBIT Growth	30.98%	46.69%	87.47%	60.89%	-46.65%	-13.46%	-24.80%	-52.21%	46.65%	-7.28%	9.98%
NOPAT Growth	40.72%	54.22%	83.57%	58.19%	-40.28%	-16.19%	-22.63%	-48.14%	26.97%	5.63%	6.05%
Net Income Growth	35.80%	51.34%	80.12%	52.01%	0.00%	-20.21%	-30.75%	-60.24%	59.12%	2.38%	27.56%
EPS Growth	40.00%	51.72%	81.71%	52.63%	0.00%	-17.61%	-30.20%	-60.00%	62.50%	2.07%	28.85%
Operating Cash Flow Growth	-149.69%	-103.54%	45.16%	25.64%	0.00%	23,017.60%	93.79%	-17.13%	0.00%	145.03%	1,870.78%
Free Cash Flow Firm Growth	-528.94%	-324.07%	-335.03%	-36.36%	13.60%	71.96%	96.61%	93.85%	160.47%	452.06%	1,554.52%
Invested Capital Growth	26.42%	26.80%	89.36%	22.33%	17.12%	8.33%	4.15%	2.72%	-5.46%	-11.82%	-17.98%
Revenue Q/Q Growth	10.42%	14.52%	-2.66%	-2.11%	-4.60%	0.23%	-4.04%	-1.60%	-0.64%	9.35%	-7.09%
EBITDA Q/Q Growth	25.99%	24.03%	-7.95%	1.10%	-65.49%	188.17%	-15.64%	-24.64%	23.13%	22.97%	-5.98%
EBIT Q/Q Growth	36.32%	32.31%	-10.70%	-0.12%	-54.80%	114.63%	-22.40%	-36.52%	38.71%	35.70%	-7.95%
NOPAT Q/Q Growth	39.61%	28.60%	-11.38%	-0.58%	-47.30%	80.48%	-18.19%	-33.36%	29.04%	50.15%	-17.87%
Net Income Q/Q Growth	39.54%	34.57%	-16.38%	-3.19%	-61.32%	154.83%	-27.44%	-44.42%	54.81%	63.97%	-9.59%
EPS Q/Q Growth	40.00%	32.33%	-15.34%	-2.68%	-61.38%	158.93%	-28.28%	-44.23%	56.90%	62.64%	-9.46%
Operating Cash Flow Q/Q Growth	-125.13%	98.15%	-12,347.45%	317.14%	0.00%	0.00%	-103.37%	2,998.51%	49.90%	67.27%	-75.63%
Free Cash Flow Firm Q/Q Growth	-39.73%	-2.22%	-187.65%	66.81%	11.46%	66.82%	65.25%	39.75%	970.44%	93.18%	43.58%
Invested Capital Q/Q Growth	6.57%	5.51%	10.66%	-1.69%	2.03%	-2.41%	6.39%	-3.04%	-6.09%	-8.97%	-1.04%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	9.54%	9.53%	9.25%	9.62%	9.17%	9.45%	8.97%	9.11%	9.83%	10.27%	10.32%
EBITDA Margin	6.40%	6.93%	6.55%	6.77%	2.45%	7.04%	6.19%	4.74%	5.87%	6.60%	6.68%
Operating Margin	5.05%	5.54%	5.24%	5.32%	2.76%	5.21%	4.60%	3.05%	4.08%	5.13%	4.80%
EBIT Margin	4.78%	5.52%	5.06%	5.17%	2.45%	5.24%	4.24%	2.73%	3.82%	4.74%	4.69%
Profit (Net Income) Margin	3.82%	4.49%	3.86%	3.81%	1.55%	3.93%	2.97%	1.68%	2.62%	3.92%	3.82%
Tax Burden Percent	86.64%	88.61%	85.34%	85.44%	90.92%	86.78%	83.84%	85.62%	82.96%	90.77%	85.68%
Interest Burden Percent	92.31%	91.79%	89.24%	86.39%	69.48%	86.43%	83.65%	71.73%	82.62%	91.25%	94.94%
Effective Tax Rate	13.36%	11.39%	14.66%	14.56%	9.08%	13.23%	16.16%	14.38%	17.04%	9.23%	14.32%
Return on Invested Capital (ROIC)	0.00%	16.33%	0.00%	0.00%	0.00%	14.25%	10.91%	7.37%	9.63%	14.10%	12.10%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	10.70%	0.00%	0.00%	0.00%	10.91%	7.30%	2.71%	4.96%	-6.54%	6.53%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.85%	0.00%	0.00%	0.00%	1.70%	1.45%	0.43%	0.64%	-0.19%	0.26%
Return on Equity (ROE)	0.00%	17.18%	0.00%	0.00%	0.00%	15.95%	12.35%	7.80%	10.28%	13.91%	12.36%
Cash Return on Invested Capital (CROIC)	-23.34%	-10.06%	-61.76%	-20.09%	-15.77%	4.67%	6.86%	6.86%	15.87%	23.64%	30.68%
Operating Return on Assets (OROA)	0.00%	7.19%	0.00%	0.00%	0.00%	6.57%	5.19%	3.28%	4.56%	5.80%	5.82%
Return on Assets (ROA)	0.00%	5.85%	0.00%	0.00%	0.00%	4.93%	3.64%	2.02%	3.12%	4.80%	4.74%
Return on Common Equity (ROCE)	0.00%	17.18%	0.00%	0.00%	0.00%	15.95%	12.35%	7.80%	10.28%	13.91%	12.36%
Return on Equity Simple (ROE_SIMPLE)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	9.96%	8.06%	8.75%	0.00%	9.09%
Net Operating Profit after Tax (NOPAT)	43	55	49	49	26	46	38	25	33	49	40
NOPAT Margin	4.38%	4.91%	4.47%	4.54%	2.51%	4.52%	3.85%	2.61%	3.39%	4.65%	4.11%
Net Nonoperating Expense Percent (NNEP)	11.16%	5.63%	-51.02%	5.01%	4.98%	3.34%	3.61%	4.67%	4.67%	20.64%	5.56%
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	2.21%	-	-	-	2.62%
Cost of Revenue to Revenue	90.46%	90.47%	90.75%	90.38%	90.83%	90.55%	91.03%	90.89%	90.17%	89.73%	89.68%
SG&A Expenses to Revenue	4.49%	3.99%	4.01%	4.30%	4.15%	4.24%	4.37%	4.92%	4.78%	5.15%	5.04%
R&D to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Expenses to Revenue	4.49%	3.99%	4.01%	4.30%	6.41%	4.24%	4.37%	6.06%	5.74%	5.15%	5.51%
Earnings before Interest and Taxes (EBIT)	47	62	55	55	25	54	42	26	37	50	46
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	63	78	72	72	25	72	61	46	56	69	65
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	2.08	2.27	2.53	2.33	2.32	2.15	2.39	2.10	2.26	2.87	3.32
Price to Tangible Book Value (P/TBV)	2.08	2.27	2.53	2.33	2.32	2.15	2.39	2.10	2.26	2.87	3.32
Price to Revenue (P/Rev)	0.00	0.65	0.00	0.00	0.00	0.62	0.74	0.66	0.73	0.96	1.11
Price to Earnings (P/E)	0.00	18.01	0.00	0.00	0.00	17.34	21.98	24.72	26.18	25.95	28.30
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	5.55%	0.00%	0.00%	0.00%	5.77%	4.55%	4.05%	3.82%	3.85%	3.53%
Enterprise Value to Invested Capital (EV/IC)	1.94	2.09	2.24	2.12	2.10	2.01	2.19	1.97	2.19	3.03	3.53
Enterprise Value to Revenue (EV/Rev)	0.00	0.70	0.00	0.00	0.00	0.66	0.79	0.71	0.75	0.94	1.08
Enterprise Value to EBITDA (EV/EBITDA)	37.93	11.36	50.12	45.44	0.00	10.76	13.05	19.22	12.52	15.95	18.05
Enterprise Value to EBIT (EV/EBIT)	0.00	15.48	0.00	0.00	0.00	14.72	18.44	19.22	18.58	23.99	26.93
Enterprise Value to NOPAT (EV/NOPAT)	0.00	17.20	0.00	0.00	0.00	16.48	20.48	20.93	20.73	25.61	29.08
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	228.17	83.28	0.00	16.82	15.31	0.00	9.61	8.49	8.67
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	44.70	32.63	29.11	13.40	12.00	10.36
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.41	0.42	0.45	0.41	0.42	0.36	0.35	0.35	0.28	0.19	0.16
Long-Term Debt to Equity	0.17	0.17	0.16	0.16	0.16	0.16	0.15	0.15	0.07	0.07	0.07
Financial Leverage	0.05	0.08	-0.01	0.14	0.18	0.16	0.20	0.16	0.13	0.03	0.04
Leverage Ratio	2.66	2.76	2.78	2.87	2.95	2.91	2.77	2.73	2.69	2.55	2.47
Compound Leverage Factor	2.45	2.53	2.48	2.48	2.05	2.51	2.32	1.96	2.22	2.33	2.34
Debt to Total Capital	29.12%	29.65%	30.98%	28.99%	29.36%	26.20%	25.92%	25.80%	21.60%	15.73%	13.77%
Short-Term Debt to Total Capital	16.75%	17.59%	19.75%	17.66%	18.18%	14.60%	14.69%	14.49%	15.98%	10.01%	7.97%
Long-Term Debt to Total Capital	12.37%	12.06%	11.24%	11.33%	11.18%	11.60%	11.24%	11.31%	5.62%	5.72%	5.80%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	70.88%	70.35%	69.02%	71.01%	70.64%	73.80%	74.08%	74.20%	78.40%	84.27%	86.23%
Debt to EBITDA	7.00	1.96	8.13	7.41	0.00	1.66	1.79	2.98	1.48	1.06	0.89
Net Debt to EBITDA	2.53	0.79	4.23	3.26	0.00	0.67	0.85	1.18	0.34	-0.43	-0.45
Long-Term Debt to EBITDA	2.98	0.80	2.95	2.90	0.00	0.74	0.77	1.31	0.39	0.39	0.37
Debt to NOPAT	0.00	2.97	0.00	0.00	0.00	2.55	2.80	3.25	2.46	1.71	1.43
Net Debt to NOPAT	0.00	1.20	0.00	0.00	0.00	1.03	1.33	1.28	0.56	-0.69	-0.73
Long-Term Debt to NOPAT	0.00	1.21	0.00	0.00	0.00	1.13	1.21	1.42	0.64	0.62	0.60
Altman Z-Score	1.62	2.77	1.80	1.80	1.75	3.10	3.24	3.11	3.28	3.68	4.01
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	1.43	1.40	1.44	1.45	1.44	1.47	1.52	1.51	1.47	1.51	1.53
Quick Ratio	0.48	0.50	0.50	0.49	0.49	0.51	0.51	0.52	0.53	0.59	0.58
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-211	-216	-621	-206	-182	-60	-21	-13	110	213	306
Operating Cash Flow to CapEx	-101.67%	-2.36%	-211.37%	401.23%	0.00%	370.39%	-10.57%	384.06%	758.17%	836.75%	202.19%
Free Cash Flow to Firm to Interest Expense	-53.79	-38.91	-90.01	-24.85	-22.15	-7.44	-2.76	-1.53	14.92	38.19	86.05
Operating Cash Flow to Interest Expense	-5.40	-0.07	-7.08	12.79	0.00	11.05	-0.40	10.59	17.81	39.47	15.09
Operating Cash Flow Less CapEx to Interest Expense	-10.72	-3.06	-10.43	9.60	0.00	8.07	-4.16	7.83	15.46	34.75	7.63
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.00	1.30	0.00	0.00	0.00	1.25	1.22	1.20	1.19	1.22	1.24
Accounts Receivable Turnover	0.00	6.06	0.00	0.00	0.00	6.02	5.90	6.11	5.83	6.17	6.31
Inventory Turnover	0.00	2.69	0.00	0.00	0.00	2.41	2.31	2.29	2.32	2.49	2.49
Fixed Asset Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Accounts Payable Turnover	0.00	4.81	0.00	0.00	0.00	5.26	5.31	5.35	5.53	5.72	5.43
Days Sales Outstanding (DSO)	0.00	60.21	0.00	0.00	0.00	60.65	61.89	59.70	62.66	59.16	57.86
Days Inventory Outstanding (DIO)	0.00	135.66	0.00	0.00	0.00	151.37	158.08	159.36	157.38	146.39	146.75
Days Payable Outstanding (DPO)	0.00	75.89	0.00	0.00	0.00	69.46	68.79	68.23	65.99	63.83	67.27
Cash Conversion Cycle (CCC)	0.00	119.98	0.00	0.00	0.00	142.56	151.19	150.83	154.05	141.71	137.34
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,215	1,282	1,419	1,395	1,423	1,389	1,478	1,433	1,345	1,225	1,212
Invested Capital Turnover	0.00	3.32	0.00	0.00	0.00	3.15	2.83	2.83	2.84	3.03	2.94
Increase / (Decrease) in Invested Capital	254	271	669	255	208	107	59	38	-78	-164	-266
Enterprise Value (EV)	2,355	2,676	3,182	2,962	2,989	2,788	3,240	2,821	2,944	3,708	4,274
Market Capitalization	2,198	2,490	2,913	2,750	2,750	2,614	3,029	2,648	2,865	3,808	4,381
Book Value per Share	$38.17	$39.54	$41.63	$42.68	$42.84	$44.19	$46.12	$45.74	$46.28	$48.66	$48.69
Tangible Book Value per Share	$38.17	$39.54	$41.63	$42.68	$42.84	$44.19	$46.12	$45.74	$46.28	$48.66	$48.69
Total Capital	1,493	1,557	1,667	1,665	1,677	1,645	1,710	1,698	1,615	1,572	1,530
Total Debt	435	462	516	483	492	431	443	438	349	247	211
Total Long-Term Debt	185	188	187	189	187	191	192	192	91	90	89
Net Debt	157	186	268	212	239	174	211	173	79	-100	-107
Capital Expenditures (CapEx)	21	17	23	26	0.00	24	29	23	17	26	27
Debt-free, Cash-free Net Working Capital (DFCFNWC)	766	808	941	886	910	843	925	875	804	644	626
Debt-free Net Working Capital (DFNWC)	1,044	1,084	1,189	1,156	1,163	1,100	1,158	1,140	1,074	991	944
Net Working Capital (NWC)	794	810	860	862	858	860	907	894	816	834	822
Net Nonoperating Expense (NNE)	5.44	4.76	6.75	7.81	9.84	6.02	8.64	8.99	7.42	7.66	2.88
Net Nonoperating Obligations (NNO)	157	186	268	212	239	174	211	173	79	-100	-107
Total Depreciation and Amortization (D&A)	16	16	16	17	0.00	18	19	19	20	20	19
Debt-free, Cash-free Net Working Capital to Revenue	0.00%	21.21%	0.00%	0.00%	0.00%	20.02%	22.58%	21.90%	20.45%	16.25%	15.83%
Debt-free Net Working Capital to Revenue	0.00%	28.44%	0.00%	0.00%	0.00%	26.12%	28.25%	28.54%	27.31%	25.02%	23.87%
Net Working Capital to Revenue	0.00%	21.25%	0.00%	0.00%	0.00%	20.42%	22.12%	22.38%	20.74%	21.05%	20.79%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$1.35	$1.81	$1.53	$1.48	$0.57	$1.46	$1.06	$0.59	$0.92	$1.51	$1.38
Adjusted Weighted Average Basic Shares Outstanding	27.74M	27.86M	27.64M	27.66M	27.56M	27.58M	27.49M	27.54M	27.36M	27.40M	27.09M
Adjusted Diluted Earnings per Share	$1.33	$1.76	$1.49	$1.45	$0.56	$1.45	$1.04	$0.58	$0.91	$1.48	$1.34
Adjusted Weighted Average Diluted Shares Outstanding	28.18M	28.44M	28.31M	28.18M	27.99M	28.11M	28.01M	27.93M	27.77M	27.91M	27.76M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	27.71M	27.63M	27.70M	27.65M	27.48M	27.47M	27.61M	27.39M	27.23M	27.09M	27.04M
Normalized Net Operating Profit after Tax (NOPAT)	43	55	49	49	47	46	38	35	40	49	44
Normalized NOPAT Margin	4.38%	4.91%	4.47%	4.54%	4.57%	4.52%	3.85%	3.59%	4.18%	4.65%	4.52%
Pre Tax Income Margin	4.41%	5.07%	4.52%	4.46%	1.70%	4.53%	3.55%	1.96%	3.15%	4.32%	4.46%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	11.95	11.19	8.04	6.68	3.04	6.60	5.47	3.19	4.96	8.92	12.89
NOPAT to Interest Expense	10.95	9.96	7.10	5.87	3.12	5.69	4.97	3.04	4.41	8.77	11.30
EBIT Less CapEx to Interest Expense	6.64	8.20	4.69	3.49	3.04	3.62	1.71	0.43	2.61	4.21	5.43
NOPAT Less CapEx to Interest Expense	5.63	6.97	3.75	2.68	3.12	2.71	1.21	0.29	2.06	4.05	3.83
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	36.45%	0.00%	0.00%	0.00%	29.44%	23.37%	0.00%	35.78%	49.80%	57.16%

Frequently Asked Questions About Plexus' Financials

When does Plexus's financial year end?

According to the most recent income statement we have on file, Plexus' fiscal year ends in September. Their fiscal year 2024 ended on September 28, 2024.

How has Plexus' net income changed over the last 9 years?

Plexus' net income appears to be on an upward trend, with a most recent value of $111.82 million in 2024, rising from $94.33 million in 2015. The previous period was $139.09 million in 2023.

What is Plexus's operating income?

Plexus's total operating income in 2024 was $167.73 million, based on the following breakdown:

Total Gross Profit: $378.53 million
Total Operating Expenses: $210.80 million

How has Plexus revenue changed over the last 9 years?

Over the last 9 years, Plexus' total revenue changed from $2.65 billion in 2015 to $3.96 billion in 2024, a change of 49.2%.

How much debt does Plexus have?

Plexus' total liabilities were at $1.83 billion at the end of 2024, a 13.2% decrease from 2023, and a 115.3% increase since 2015.

How much cash does Plexus have?

In the past 9 years, Plexus' cash and equivalents has ranged from $223.76 million in 2019 to $568.86 million in 2017, and is currently $345.11 million as of their latest financial filing in 2024.

How has Plexus' book value per share changed over the last 9 years?

Over the last 9 years, Plexus' book value per share changed from 25.04 in 2015 to 48.66 in 2024, a change of 94.3%.

Remove Ads

Related Companies

This page (NASDAQ:PLXS) was last updated on 4/16/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Plexus (PLXS) Financials

Frequently Asked Questions About Plexus' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Plexus (PLXS) Financials

Annual Income Statements for Plexus

Quarterly Income Statements for Plexus

Annual Cash Flow Statements for Plexus

Quarterly Cash Flow Statements for Plexus

Annual Balance Sheets for Plexus

Quarterly Balance Sheets for Plexus

Annual Metrics and Ratios for Plexus

Quarterly Metrics and Ratios for Plexus

Frequently Asked Questions About Plexus' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools